Index/Topics/Cytochrome P450 Enzymes

Cytochrome P450 Enzymes

The role of CYP2C9, CYP3A4, and CYP2C19 enzymes in metabolizing warfarin

Fact-Checks

5 results
Jan 12, 2026
Most Viewed

What drug interactions have been documented for Bacopa monnieri and how strong is the evidence?

Bacopa monnieri has been documented to interact with drugs primarily by inhibiting multiple cytochrome P450 (CYP) enzymes—especially CYP3A4, CYP2C9, CYP2C19 and CYP1A2—which can increase blood levels ...

Jan 15, 2026
Most Viewed

What is the active ingredient profile of garaherb and how does it affect drug metabolism?

GaraHerb’s public materials and third‑party reviews provide an inconsistent and incomplete picture of its active ingredient profile: official product pages primarily list capsule excipients while mult...

Jan 16, 2026

Do different CBD product carriers (MCT oil, grapeseed oil, ethanol tinctures) affect CBD absorption enough to change warfarin interaction risk?

Different CBD carriers (MCT oil, grapeseed oil, ethanol tinctures) change how quickly and how much CBD enters the bloodstream, and because CBD–warfarin interactions reported in the literature are conc...

Jan 16, 2026

Cbd oil (grapeseed oil base) effects when taken with warfarin

CBD products have been reported to raise warfarin activity—most often by increasing INR and thus bleeding risk—likely via inhibition of cytochrome P450 enzymes that metabolize warfarin, but the eviden...

Jan 5, 2026

Which medications, supplements, or medical conditions interact dangerously with garaherb?

Garaherb’s public materials present it as a plant‑based male enhancement supplement without a full, clearly published ingredient list on the product site , and independent reviews emphasize it is a di...